This digital shopping assistant relocated to Texas last year to focus on the business-friendly market. Courtesy of ModeSens

Former Microsoft engineer Brian Li wanted to help his wife, Jing Leng, a personal shopper, make smart purchases for her clients seeking luxury clothing. The couple found it impractical and time consuming to sift through multiple websites in search of clothing that was the best fit.

Li, now CEO of ModeSens, was inspired in 2015 to develop a personal shopping tool. The name comes from rearranging the French phrase "sens de la mode," which means "fashion sense."

"It started out as something that Brian worked on in his free time. But after they started using it, they realized that other people would find it useful," says Krystle Craycraft, CMO of ModeSens. "Another resource like this does not exist. We are the only company that aggregates information at the product level, presenting information to consumers in a way that is easy to navigate, and all in one place."

Since launching in 2015 in Seattle, the company relocated to Texas last year. Now, headquartered in Dallas, the company is building a large pool of users in major cities throughout Texas. ModeSens sees a growing connection with Houston in terms of customers and fashion retailers.

Li moved the business "because Texas is a good place to do business," Craycraft says. "Many businesses are following the trend of moving to Texas because of the great climate to do business in. We love Texas."

ModeSens, using its database of information, gives luxury fashion shoppers important information about products as they search, making for a more efficient, satisfying purchase. For a given item, ModeSens provides members a list of retailers who have the item in stock, the price comparison across retailers, available colors, designer information, product reviews, special promotions, and more.

You can download the free app, create a free account, and start saving on luxury goods by searching the site or scanning barcodes in the store. As ModeSens specializes in luxury goods, they partner with almost 200 brands such as Neiman Marcus, SAKS, Gucci, Dolce & Gobana, Lane Crawford and other premier designers.

"We connect with clients through several different affiliate networks as well as direct partnerships," says Craycraft. ModeSens partners exclusively with high-end retailers, filling a specific niche for the first time.

Leng, serving as the Fashion Director at ModeSens, works with these retail partners, curating content and promoting their products in a way that helps customers buy confidently.

"The customer is the focus of ModeSens; getting them what they need to make an informed decision is our top priority," says Craycraft. "Other fashion shopping platforms show products from Forever 21 all the way up to luxury brands, but for our customers looking for luxury products, a lot of those stores are just not relevant to them. Sorting through them becomes tedious."

ModeSens puts the answers to at customers' questions at their fingertips, once signed up with a free membership.

With the brand-new release of the barcode scanning feature, customers can have access to the same comparative information while physically in a store, as well as online.

"This is a total game-changer in the industry; there is no one else doing this," says Craycraft.

Using the app, shoppers simply scan the barcode of any of the many retailers who are partnered with ModeSens, revealing detailed information that can guide their purchase.

ModeSens is building an online community of luxury shoppers that can collaborate to find exactly what they are looking for in an authentic way. Through the website, members can upload pictures of the products that they have acquired, write reviews, provide helpful information to others, and ask questions.

"We want this to be a place where anyone can share their thoughts, and photos without feeling too intimidated to contribute," Craycraft says.

OrchidBox's smart terrarium fits on your desktop. Courtesy OrchidBox

Desktop terrarium startup promises plants that never die

Growing business

A Dallas startup has invented a smart terrarium with minimal maintenance designed to keep your plants alive. Called OrchidBox, it handles everything from easy succulents to hard-to-grow plants like the Venus flytrap.

The technology senses when the plant needs water and syncs with the sun for proper lighting.

Founder Nathan Hollis, a 26-year-old Dallas native, used his background in computer science and his love of plants to create an acrylic box equipped with LED lighting and a watering system.

The box measures 4x4x7 inches — small enough to fit on your work desk or bedside table. You can grow any plant that fits inside the box. An app allows you to select a pre-designed environment for your plant, and you can set a schedule for how much light and water it needs.

Hollis has a huge plant collection at home, some of which he has owned for seven years.

"It's sad, I don't think young people understand just how diverse our wildlife is, and we are losing more and more plant species every day," he says.

The name OrchidBox was selected to educate people about plant varieties and endangered species.

"While most people think of the stereotypical store-bought orchids, there are actually 50,000 species of orchids, some that are very, very bizarre," he says. "Most people don't know that, and some don't even know what an orchid is, so we wanted to take the opportunity to teach people."

The mini terrarium concept has been three years in the making. When he was in college, Hollis utilized his programming and mechanical engineering education to make climate-controlled devices that were larger, before sizing down his design to something that could adorn people's tabletops.

The company has competitors, such as Biopod Smart Microhabitat and EcoQube Air, but OrchidBox is the only company with a patent, said Taylor Mason, whose company It Crowd Marketing is helping Hollis with the media buzz.

Hollis had a full-time job but quit in February to focus exclusively on this venture. The product is available for pre-order which you can do here.

---

This story originally appeared on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston geothermal unicorn Fervo officially files for IPO

going public

Fervo Energy has officially filed for IPO.

The Houston-based geothermal unicorn filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission on April 17 to list its Class A common stock on the Nasdaq exchange. Fervo intends to be listed under the ticker symbol "FRVO."

The number and price of the shares have not yet been determined, according to a news release from Fervo. J.P. Morgan, BofA Securities, RBC Capital Markets and Barclays are leading the offering.

The highly anticipated filing comes as Fervo readies its flagship Cape Station geothermal project to deliver its first power later this year

"Today, miles-long lines for gasoline have been replaced by lines for electricity. Tech companies compete for megawatts to claim AI market share. Manufacturers jockey for power to strengthen American industry. Utilities demand clean, firm electricity to stabilize the grid," Fervo CEO Tim Latimer shared in the filing. "Fervo is prepared to serve all of these customers. Not with complex, idiosyncratic projects but with a simplified, standardized product capable of delivering around-the-clock, carbon-free power using proven oil and gas technology."

Fervo has been preparing to file for IPO for months. Axios Pro first reported that the company "quietly" filed for an IPO in January and estimated it would be valued between $2 billion and $3 billion.

Fervo also closed $421 million in non-recourse debt financing for the first phase of Cape Station last month and raised a $462 million Series E in December. The company also announced the addition of four heavyweights to its board of directors last week, including Meg Whitman, former CEO of eBay, Hewlett-Packard, and Spring-based HPE.

Fervo reported a net loss of $70.5 million for the 2025 fiscal year in the S-1 filing and a loss of $41.1 million in 2024.

Tracxn.com estimates that Fervo has raised $1.12 billion over 12 funding rounds. The company was founded in 2017 by Latimer and CTO Jack Norbeck.

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

New UT Austin med center, anchored by MD Anderson, gets $1 billion gift

Future of Health

A donation announced Tuesday, April 21, breaks a major record at the University of Texas at Austin. Michael and Susan Dell are now UT Austin's first supporters to give $1 billion. In response, the university will create the UT Dell Campus for Advanced Research and the UT Dell Medical Center to "advance human health," per a press release.

The release also records "significant support" for undergraduate scholarships, student housing, and the Texas Advanced Computing Center for supercomputing research.

Both the new research campus and the UT Dell Medical Center will integrate advanced computing into their research and practices. At the medical center, the university hopes that will lead to "earlier detection, more precise and personalized care, and better health outcomes." The University of Texas MD Anderson Cancer Center will also be integrated into the new medical center.

That comes with a numeric goal measured in 10s: raise $10 billion and rank among the top 10 medical centers in the U.S., both in the next decade.

In the shorter term, the university will break ground on the medical center with architecture firm Skidmore, Owings & Merrill (SOM) "later this year."

“UT Austin, where Dell Technologies was founded from a dorm room, has always been a place where bold ideas become real-world impact,” said Michael and Susan Dell in a joint statement.

They continued, “What makes this moment so meaningful is the opportunity to build something that brings every part of the journey together — from how students learn, to how discoveries are made, to how care reaches families. By bringing together medicine, science and computing in one campus designed for the AI era, UT can create more opportunity, deliver better outcomes, and build a stronger future for communities across Texas and beyond.”

This is the second major gift this year for the planned multibillion-dollar medical center. In January, Tench Coxe, a former venture capitalist who’s a major shareholder in chipmaking giant Nvidia, and Simone Coxe, co-founder and former CEO of the Blanc & Otus PR firm, contributed $100 million$100 million.

Baylor scientist lands $2M grant to explore links between viruses and Alzheimer’s

Alzheimer’s research

A Baylor College of Medicine scientist will begin exploring the possible link between Alzheimer’s disease and viral infections thanks to a $2 million grant awarded in March.

Dr. Ryan S. Dhindsa is an assistant professor of pathology & immunology at Baylor and a principal investigator at Texas Children’s Duncan Neurological Research Institute (Duncan NRI). He hypothesizes that Alzheimer’s may have some link to previous viral infections contracted by the patient. To study this intriguing possibility, the American Brain Foundation has gifted him the Cure One, Cure Many award in neuroinflammation.

“It is an honor to receive this support from the Cure One, Cure Many Award. Viral infections are emerging as a major, underappreciated driver of Alzheimer's disease, and this award will allow our team to conduct the most comprehensive screen of viral exposures and host genetics in Alzheimer's to date, spanning over a million individuals,” Dhindsa said in a news release. “Our goal is to identify which viruses matter most, why some people are more vulnerable than others, and ultimately move the field closer to new therapeutic strategies for patients.”

Roughly 150 million people worldwide will suffer from Alzheimer’s by 2050, making it the most common cause of dementia in the world. Despite this, scientists are still at a loss as to what exactly causes it.

Dhindsa’s research is part of a new range of theories that certain viral infections may trigger Alzheimer’s. His team will take a two-fold approach. First, they will analyze the medical records of more than a million individuals looking for patterns. Second, they will analyze viral DNA in stem cell-derived brain cells to see how the infections could contribute to neurological decay. The scale of the genomic data gathering is unprecedented and may highlight a link that traditional studies have missed.

Also joining the project are Dr. Caleb Lareau of Memorial Sloan Kettering Cancer Center and Dr. Artem Babaian of the University of Toronto. Should a link be found, it would open the door to using anti-virals to prevent or treat Alzheimer’s.